Journey Clinical operates a health-tech platform that connects licensed psychotherapists with an in-house medical team to deliver ketamine-assisted psychotherapy (KAP) across the United States. The company manages patient eligibility assessment, treatment planning, psychiatric medication management, and clinical outcomes monitoring, while therapists in its network provide the psychotherapy component.
The platform is designed to expand access to psychedelic-assisted psychotherapy in a structured, medically supervised environment. According to the company, 87% of KAP patients report improvement in depression and anxiety clinical scores after two medical visits. Journey Clinical claims to operate the largest network of licensed therapists providing this treatment in the country.
The collaborative care model reflects an emphasis on both safety and clinical effectiveness. The in-house medical team maintains oversight of treatment protocols and patient progression, while the network of licensed psychotherapists delivers the therapeutic component. This structure distinguishes the offering in a nascent market where clinical standards and practitioner credentials remain variable.